KEYS vs TRDA · P/E 57, rev $4.98B vs P/E 12, rev $210.8M
Keysight Technologies Inc (KEYS) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
KEYS currently screens at market cap $59.84B and trailing P/E 56.5. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the KEYS and TRDA stock pages for the full models.
Not investment advice.